Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
460 participants
OBSERVATIONAL
2005-01-31
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects
NCT02952378
Oral Care Study on Burn Patients
NCT01302457
Soluble Factors in the Serum of Severely Burned Patients
NCT02549079
Effect of Enteral Albumin on Healing of Superficial Partial Thickness Fresh Flame Burns of Adults
NCT03709069
Large Burn Outcome Study
NCT00731887
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each participating site will retrospectively review 20 charts of consecutive admissions with at least a 20% TBSA burn. In addition, each site will collect data prospectively on 20 more patients with 20% TBSA burns. Prospective data is requested in order to capture as close as possible to "real time" the reasons physicians choose to give albumin. No Protected Health Information (PHI) will be recorded.
Data will be analyzed for patterns of albumin use and reasons for albumin administration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Comfort care only for the burn injury
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Surgery, University of North Carolina at Chapel Hill
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruce A. Cairns, MD
Role: PRINCIPAL_INVESTIGATOR
North Carolina Jaycee Burn Center, University of North Carolina Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona Burn Center, Maricopa Medical Center
Phoenix, Arizona, United States
Bothin Burn Center, Saint Francis Memorial Hospital
San Francisco, California, United States
Shands at the University of Florida Burn Center
Gainesville, Florida, United States
Joseph M Still Research Foundation Inc and Doctors Hospital of Augusta
Augusta, Georgia, United States
Bothin Burn Center, University of Kansas Hospital
Kansas City, Kansas, United States
Regions Hospital Burn Center
Saint Paul, Minnesota, United States
North Carolina Jaycee Burn Center, University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
Paul and Carol David Foundation Burn Institute, Akron Children's Hospital
Akron, Ohio, United States
Shriners Hospitals for Children
Cincinnati, Ohio, United States
Oregon Burn Center, Legacy Health System
Portland, Oregon, United States
University of Utah Hospitals Burn Center
Salt Lake City, Utah, United States
Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-1392
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.